Works by Ji Young Lim


Results: 80
    1

    Oral proteasome inhibitor with strong preclinical efficacy in myeloma models.

    Published in:
    2016
    By:
    • Jonghoon Park;
    • Eok Park;
    • Cheol-Kyu Jung;
    • Seung-Wan Kang;
    • Byung Gyu Kim;
    • Youngjoo Jung;
    • Tae Hun Kim;
    • Ji-Young Lim;
    • Sung-Eun Lee;
    • Chang-Ki Min;
    • Kwang-Ai Won;
    • Park, Jonghoon;
    • Park, Eok;
    • Jung, Cheol-Kyu;
    • Kang, Seung-Wan;
    • Kim, Byung Gyu;
    • Jung, Youngjoo;
    • Kim, Tae Hun;
    • Lim, Ji-Young;
    • Lee, Sung-Eun
    Publication type:
    journal article
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47

    Circulating immune cell phenotype can predict the outcome of lenalidomide plus low-dose dexamethasone treatment in patients with refractory/relapsed multiple myeloma.

    Published in:
    Cancer Immunology, Immunotherapy, 2016, v. 65, n. 8, p. 983, doi. 10.1007/s00262-016-1861-2
    By:
    • Lee, Sung-Eun;
    • Lim, Ji-Young;
    • Ryu, Da-Bin;
    • Kim, Tae;
    • Yoon, Jae-Ho;
    • Cho, Byung-Sik;
    • Eom, Ki-Seong;
    • Kim, Yoo-Jin;
    • Kim, Hee-Je;
    • Lee, Seok;
    • Cho, Seok-Goo;
    • Kim, Dong-Wook;
    • Lee, Jong-Wook;
    • Min, Woo-Sung;
    • Kim, Myungshin;
    • Min, Chang-Ki
    Publication type:
    Article
    48
    49
    50